Therefore, a high level of UBE2T has been depicted in different kinds of cancer, including lung cancer [33], hepatocellular carcinoma [15], and renal cell carcinoma [34], suggesting the tumor-promoting role of UBE2T, which has the potential to act as a promising drug target in cancer therapy. The gene discussed is UBE2T; the disease is hepatocellular carcinoma.